About
Peptide Therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyNJ, NY, PA
Team (5)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
254
By Phase
PHASE2/PHASE3: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07214311Lead Sponsor
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
PHASE2/PHASE3Not yet recruiting
240 participants
Started: Dec 31, 2025 · Completed: Sep 30, 2028
NCT05137314Lead Sponsor
Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)
PHASE1Completed
14 participants
Started: Mar 31, 2022 · Completed: Mar 19, 2024
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...